Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A humanized mouse model for a common beta0-thalassemia mutation.

Duangporn Jamsai1, Faten Zaibak, Wantana Khongnium

  • 1CAGT Research Group, The Murdoch Children's Research Institute, Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Flemington Road, Melbourne, VIC 3052, Australia.

Genomics
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thalassaemia.

Nature reviews. Disease primers·2026
Same author

Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice.

American journal of hematology·2026
Same author

Neutrophil extracellular traps induced by activated platelets as a cause of neutrophil-platelet aggregation in β-thalassaemia/haemoglobin E patients.

British journal of haematology·2026
Same author

CCND3 Suppression Ameliorates β-Thalassaemia in a Murine Disease Model: A Potential Therapeutic Strategy.

Cells·2026
Same author

Beyond iron deficiency: A comprehensive national survey of anaemia etiology in Sri Lankan young adults.

Scientific reports·2026
Same author

Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells.

Molecular medicine (Cambridge, Mass.)·2026

Researchers created a mouse model for beta-thalassemia, a blood disorder. This model, carrying a common mutation, aids in developing gene therapies and studying treatments in a humanized environment.

Area of Science:

  • Genetics
  • Hematology
  • Animal Models

Background:

  • Beta-thalassemia is a genetic blood disorder requiring accurate animal models for therapeutic development.
  • Existing models may not fully recapitulate human disease phenotypes and genotypes.
  • The codons 41-42 (-TTCT) deletion is a prevalent mutation in beta-thalassemia, particularly in Southeast Asia.

Purpose of the Study:

  • To generate and characterize a novel mouse model for beta-thalassemia.
  • To investigate the utility of this model for gene therapy and in vivo studies of therapeutic interventions.
  • To assess the phenotypic complementation in a "humanized" mouse model with a specific beta-thalassemia mutation.

Main Methods:

  • Generation of a mouse model with the human beta-globin locus containing the codons 41-42 (-TTCT) beta-thalassemia mutation.

Related Experiment Videos

  • Analysis of gamma-globin production in embryonic stages.
  • Assessment of mutant human beta-globin mRNA expression.
  • Evaluation of phenotypic complementation in the absence of functional murine beta-globin genes.

    • Main Results:

    • Successful generation of a mouse model with the specific beta-thalassemia mutation within the human beta-globin locus.
    • Demonstrated low-level production of gamma-globins and mutant human beta-globin mRNA in embryonic development.
    • Observed a lack of phenotypic complementation of the murine beta-globin gene knockout, unlike in normal human beta-globin locus transgenic mice.

    Conclusions:

    • The generated mouse model is valuable for studying gene correction strategies in hematopoietic stem cells.
    • This model provides a "humanized" in vivo environment for investigating the efficacy of HbF inducers.
    • Further research with this model can advance therapeutic approaches for beta-thalassemia.